Globotriaosylceramide inhibits iNKT-cell activation in a CD1d-dependent manner

European Journal of Immunology

Volumn 46, Issue 1, 2016, Pages 147-153

  Pereira, Catia S ^a,b,c   Sa Miranda, Clara ^a,b   De Libero, Gennaro ^d,e   Mori, Lucia ^d,e   Macedo, Maria Fatima ^a,b,f  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d AGENCY FOR SCIENCE   (Singapore)

^e UNIVERSITY OF BASEL   (Switzerland)

^f UNIVERSITY OF AVEIRO   (Portugal)

Author keywords

CD1d; Fabry disease; Globotriaosylceramide (Gb3); INKT cells; Lysosomal storage diseases

Indexed keywords

CD1D ANTIGEN; GLOBOTRIAOSYLCERAMIDE; GLYCOSPHINGOLIPID; MONOCLONAL ANTIBODY; CERAMIDE TRIHEXOSIDE;

ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; FABRY DISEASE; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; ANIMAL; C57BL MOUSE; DISEASE MODEL; FLOW CYTOMETRY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD1D; DISEASE MODELS, ANIMAL; FABRY DISEASE; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; NATURAL KILLER T-CELLS; TRIHEXOSYLCERAMIDES;

EID: 84953835270     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201545725     Document Type: Article

References (17)

1. Rozenfeld, P., Agriello, E., Francesco, N., Martinez, P. and Fossati, C., Leukocyte perturbation associated with Fabry disease. J. Inherit. Metab. Dis. 2009. 32: 67-77.
2. Pisani, A., Visciano, B., Roux, G. D., Sabbatini, M., Porto, C., Parenti, G. and Imbriaco, M., Enzyme replacement therapy in patients with Fabry disease: state of the art and review of the literature. Mol. Genet. Metab. 2012. 107: 267-275.
3. Prigozy, T. I., Naidenko, O., Qasba, P., Elewaut, D., Brossay, L., Khurana, A., Natori, T. et al. Glycolipid antigen processing for presentation by CD1d molecules. Science 2001. 291: 664-667.
4. Gadola, S. D., Silk, J. D., Jeans, A., Illarionov, P. A., Salio, M., Besra, G. S., Dwek, R. et al., Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases. J. Exp. Med. 2006. 203: 2293-303.
5. Balreira, A., Macedo, M. F., Girão, C., Rodrigues, L. G., Oliveira, J. P., Sá Miranda, M. C. and Arosa, F. A. Anomalies in conventional T and invariant natural killer T-cell populations in Fabry mice but not in Fabry patients. Br. J. Haematol. 2008. 143: 601-604.
6. Macedo, M. F., Quinta, R., Pereira, C. S. and Sa Miranda, M. C., Enzyme replacement therapy partially prevents invariant Natural Killer T cell deficiency in the Fabry disease mouse model. Mol. Genet. Metab. 2012. 106: 83-91.
7. Godfrey, D. I., Stankovic, S. and Baxter, A. G.. Raising the NKT cell family. Nat. Immunol. 2010. 11: 197-206.
8. Kain, L., Webb, B., Anderson, B. L., Deng, S., Holt, M., Costanzo, A., Zhao, M. et al., The identification of the endogenous ligands of natural killer T cells reveals the presence of mammalian α-linked glycosylceramides. Immunity 2014. 41: 543-554.
9. Pereira, C. S., Azevedo, O., Maia, M. L., Dias, A. F., Sa-Miranda, C. and Macedo, M. F., Invariant natural killer T cells are phenotypically and functionally altered in Fabry disease. Mol. Genet. Metab. 2013. 108: 241-248.
10. Darmoise, A., Teneberg, S., Bouzonville, L., Brady, R. O., Beck, M., Kaufmann, S. H. E. and Winau, F., Lysosomal alpha-galactosidase controls the generation of self lipid antigens for natural killer T cells. Immunity 2010. 33: 216-228.
11. Porubsky, S., Speak, A. O., Salio, M., Jennemann, R., Bonrouhi, M., Zafarulla, R., Singh, Y. et al., Globosides but not isoglobosides can impact the development of invariant NKT cells and their interaction with dendritic cells. J. Immunol. 2012. 189: 3007-3017.
12. Zhou, D., Mattner, J., Cantu, C., Schrantz, N., Yin, N., Gao, Y., Sagiv, Y. et al., Lysosomal glycosphingolipid recognition by NKT cells. Science 2004. 306: 1786-1789.
13. Yin, N., Long, X., Goff, R. D., Zhou, D., Mattner, J., Mezard, P., Saint, Teyton, L. et al., Alpha anomers of iGb3 and Gb3 stimulate cytokine production by natural killer T cells. ACS Chem. Biol. 2009. 4: 191-197.
14. Pellicci, D. G., Clarke, A. J., Patel, O., Mallevaey, T., Beddoe, T., Le Nours, J., Uldrich, A. P. et al., Recognition of β-linked self glycolipids mediated by natural killer T cell antigen receptors. Nat. Immunol. 2011. 12: 827-833.
15. Schümann, J., Facciotti, F., Panza, L., Michieletti, M., Compostella, F., Collmann, A., Mori, L. et al., Differential alteration of lipid antigen presentation to NKT cells due to imbalances in lipid metabolism. Eur. J. Immunol. 2007. 37: 1431-1441.
16. Kanamori, M., Tasumi, Y., Iyoda, T., Ushida, M. and Inaba, K., Sulfatide inhibits α-galactosylceramide presentation by dendritic cells. Int. Immunol. 2012. 24: 129-36.
17. Yu, E. D., Girardi, E., Wang, J., Mac, T. T., Yu, K. O. A., Van Calenbergh, S., Porcelli, S. A. et al., Structural basis for the recognition of C20:2-αGalCer by the invariant natural killer T cell receptor-like antibody L363. J. Biol. Chem. 2012. 287: 1269-1278.